Publication & Citation Trends
Publications
174 total
Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer
Cited by 390
OpenAlex
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto—GBG 69): a randomised, phase 3 trial
Cited by 409
OpenAlex
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Cited by 1,020
OpenAlex
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Cited by 2,647
OpenAlex
Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study PDF
Cited by 554
OpenAlex
Doxorubicin With Cyclophosphamide Followed by Docetaxel Every 21 Days Compared With Doxorubicin and Docetaxel Every 14 Days As Preoperative Treatment in Operable Breast Cancer: The GEPARDUO Study of the German Breast Group PDF
Cited by 419
OpenAlex
Research Topics
Breast Cancer Treatment Studies
(72)
Cancer Treatment and Pharmacology
(40)
HER2/EGFR in Cancer Research
(38)
Breast Lesions and Carcinomas
(24)
Ovarian cancer diagnosis and treatment
(22)
Affiliations
Goethe University Frankfurt
German Cancer Research Center
Friedrich-Alexander-Universität Erlangen-Nürnberg
Heidelberg University
Universidade Federal de Pernambuco